Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Gdf-15 Level Predict Progression to Multiple Organ Failure in Patients With Septic Shock

NCT06808100 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT06808100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06808100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Gdf-15 Level Predict Progression to Multiple Organ Failure in Patients With Septic Shock
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 1, 2025
Completion date
April 30, 2026
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multi organ failure, sepsis, septic shock